PB 46 of 2013
National Health (Listed drugs on F1 or F2) Amendment Determination 2013 (No. 3)
National Health Act 1953
I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the
Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.
Dated 26 July 2013
ADRIANA PLATONA
Assistant Secretary
Pharmaceutical Evaluation Branch
Pharmaceutical Benefits Division
Department of Health and Ageing
Part 1 Preliminary
1 Name of Determination
(1) This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2013 (No. 3).
(2) This Determination may also be cited as PB 46 of 2013.
2 Commencement
This Determination commences on 1 August 2013.
3 Amendment of National Health (Listed drugs on F1 or F2) Determination 2010
Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).
Schedule 1 Amendments
(Section 3)
[1] Schedule 1, after item dealing with Abciximab
Insert
Abiraterone
[2] Schedule 1, after item dealing with Balsalazide
Omit
BCG Immunotherapeutic (Bacillus Calmette-Guerin/Connaught strain)
BCG-TICE (Bacillus Calmette-Guerin/Tice strain)
Insert
Bacillus Calmette and Guerin Connaught strain
Bacillus Calmette and Guerin, Tice strain
[3] Schedule 1, after item dealing with Glycerol
Insert
Glycomacropeptide and essential amino acids
Glycomacropeptide and essential amino acids with vitamins and minerals
[4] Schedule 1, after item dealing with Interferon gamma-1b
Insert
Ipilimumab
[5] Schedule 1, after item dealing with Miconazole
Insert
Mifepristone
[6] Schedule 1, after item dealing with Minoxidil
Omit
Misoprostol
[7] Schedule 1, after item dealing with Modafinil
Omit
Montelukast
[8] Schedule 2, after item dealing with Candesartan
Insert
Candesartan with Hydrochlorothiazide
[9] Schedule 2, after item dealing with Lamivudine
Insert
Lamivudine with Zidovudine
[10] Schedule 2, after item dealing with Mirtazapine
Insert
Misoprostol
[11] Schedule 2, after item dealing with Mometasone
Insert
Montelukast
[12] Schedule 2, after item dealing with Telmisartan
Insert
Telmisartan with Hydrochlorothiazide